Patent · US Active

Crystalline forms of a compound for treating or preventing gout or hyperuricemia

US12145917B2 · kind B2 · utility

1Cited by
16References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2019
Grant dateNov 19, 2024
Priority date—
Expiry dateSep 18, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are crystalline forms of (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, and solvates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.